We partner with leading clinical researchers and laboratory professionals to deliver breakthrough after breakthrough. Each one helps improve care for millions of patients living with autoimmune diseases through enhanced quality and efficiency.
What’s our latest breakthrough?
QUANTA Flash HMGCR help diagnose a form of statin-associated necrotizing myopathy which is positive by anti-HMGCR and not usually detected by other myopathy/myositis biomarkers.
How are we advancing the quality and efficiency of autoimmune testing?
NOVA Lite DAPI reagents, used in combination with NOVA View, provide improved quality for IFA testing with an automated process that can reduce labor hours and hands-on time in the lab.
How do we increase detection rates for APS?
QUANTA Lite anti-PS/PT is designed to increase detection rates for diagnosing APS by improving sensitivity, without sacrificing specificity. It can even be used to aid diagnosis when patients have already started treatment with anti-coagulation therapy.
NEWS & EVENTS
Keep track of the latest developments.
Check out our latest news and events in autoimmune diagnostics from all over the world.
It All Starts With People
Our talent is, without a question, our most important asset. Our employees are the face of Inova, and they represent our values in their day-to-day interactions with our stakeholders